Medical Science & Therapeutics

From groundbreaking clinical trials to real-world prescribing pathways, Medical Science & Therapeutics is Hemp Gazette’s definitive hub for evidence-based cannabis medicine. We track the latest peer-reviewed research on cannabinoids such as CBD, THC, CBG, and CBN — covering pharmacology, drug interactions, dosing protocols, and condition-specific efficacy for chronic pain, epilepsy, insomnia, PTSD, and more. Whether you’re a clinician evaluating the evidence, a patient navigating access, or a researcher following trial endpoints, this section delivers the science behind the headlines.

Our coverage spans the full translational pipeline: from preclinical studies and Phase I–III clinical trials through to regulatory approvals, TGA Special Access Scheme (SAS-B) updates, and Authorised Prescriber frameworks in Australia and internationally. As medicinal cannabis policy evolves at pace across the globe, this category provides the trusted, referenced reporting that healthcare professionals and informed consumers rely on to make better decisions.